Blood Flow Restriction Strength Training in Professional Soccer Players
NCT ID: NCT04630951
Last Updated: 2023-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2020-10-05
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Flow Restriction and Recovery in Soccer Players
NCT05097027
Effects of Aerobic Blood Flow Restriction
NCT06105697
Effectiveness of Recovery Protocols Combination in Soccer Players
NCT04841733
Resistance Training With Blood Flow Restriction in Hemophilia
NCT05568524
Performance Testing in Young Soccer Players
NCT04456374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants are soccer players of RCD Mallorca (Second Spanish Football Division) and RCD Mallorca B (Third Spanish Football Division).Before to start the study, every participant will receive an informed consent about the clinical study. This informed consent will be signed by them according to Declaration of Helsinki. At the same time, the data will be anonymized and only the main researcher of the study will have access to it, to ensure compliance with the Data Protection Law.
W-UP:
The warm-up will consist of 5 minutes running slow (treadmill), 5 minutes mobility, and 5 minutes of running exercises. In addition, the warm-up will contain a familiarization with the jump test
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Strength training based on low loads with blood flow restriction (Experimental group I)
1. Squat
2. Single Deadlift
3. Back Squat
Blood Flow Restriction Strength training with low load
Low Load (20-50% 1RM), 4 set of 30/15/15/15 repetitions, 30 seconds resting between sets.
Strenght training based on high loads (Experimental group II)
1. Squat
2. Single Deadlift
3. Back Squat
High Load Strength Training
High Load (60-80% 1RM) 4 sets of 8 repetitions, 2 minutes resting between sets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restriction Strength training with low load
Low Load (20-50% 1RM), 4 set of 30/15/15/15 repetitions, 30 seconds resting between sets.
High Load Strength Training
High Load (60-80% 1RM) 4 sets of 8 repetitions, 2 minutes resting between sets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 1 years experience minimun in the division.
Exclusion Criteria
14 Years
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Balearic Islands
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalia Romero Franco
Role: STUDY_DIRECTOR
University of Balearic Islands
Christian Castilla López
Role: PRINCIPAL_INVESTIGATOR
University of Balearic Islands
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christian
Palma de Mallorca, Balearic Islands, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
160CER20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.